Triple negative breast cancers (TNBC) are phenotypically defined as lacking estrogen (ER) and progesterone (PR) receptors, as well as human epidermal growth factor receptor 2 (HER2) [6]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.